|
CN107278202A
|
|
Heterocycle ITK inhibitor for treating inflammation and cancer
|
|
WO2015112847A1
|
|
Arylpyridinone itk inhibitors for treating inflammation and cancer
|
|
KR20160104729A
|
|
Substituted pyroolopyridines and pyrrolopyrazines for treating cancer or inflammatory diseases
|
|
US2015210671A1
|
|
Arylpyridinone ITK inhibitors for treating inflammation and cancer
|
|
WO2014018888A1
|
|
4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as tak1 inhibitors in disease treatment
|
|
US2013274272A1
|
|
Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
|
|
US2013143906A1
|
|
Substituted pyrimidinone-phenyl-pyrimidinyl compounds
|
|
WO2012078673A1
|
|
Substituted pyridine urea compounds
|
|
WO2012078687A1
|
|
Substituted pyrimidine urea compounds
|
|
WO2012078674A1
|
|
Substituted indole/indazole-pyrimidinyl compounds
|
